CDER New November 20, 2014

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

November 19, 2014


New and Generic Drug Approvals

November 18, 2014

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Children's Fexofenadine Hydrochloride Allergy fexofenadine hydrochloride Suspension;Oral Actavis Mid Atlantic Approval
Children's Fexofenadine Hydrochloride Hives fexofenadine hydrochloride Suspension;Oral Actavis Mid Atlantic Approval
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride fexofenadine hydrochloride; pseudoephedrine hydrochloride Tablet, Extended Release;Oral Dr Reddys Labs Ltd Approval
Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride fexofenadine hydrochloride; pseudoephedrine hydrochloride Tablet, Extended Release;Oral Dr Reddys Labs Ltd Approval
Paricalcitol paricalcitol Injectable;Injection Hikma Approval
Saphris asenapine maleate Tablet;Sublingual Forest Labs Inc Labeling Revision
Votrient pazopanib hydrochloride Tablet;Oral Glaxosmithkline Efficacy Supplement with Clinical Data to Support

 


This email was sent to rssproject471@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

Postingan terkait:

Belum ada tanggapan untuk "CDER New November 20, 2014"

Post a Comment